AI assistant
Sending…
NRX Pharmaceuticals, Inc. — Director's Dealing 2021
May 26, 2021
34346_dirs_2021-05-25_9222f315-aa9a-48e3-92df-05045c9e933a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NRX Pharmaceuticals, Inc. (BRPA)
CIK: 0001719406
Period of Report: 2021-05-24
Reporting Person: BRAC Lending Group LLC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-24 | Common Stock | D | 869565 | — | Disposed | 562435 | Direct |
More from NRX Pharmaceuticals, Inc.
Capital/Financing Update
2026
Jun 4
Share Issue/Capital Change
2026
Jun 3
Capital/Financing Update
2026
Jun 2
Capital/Financing Update
2026
Jun 2
Interim / Quarterly Report
2026
May 15
Annual Report
2026
Mar 23
Regulatory Filings
2026
Feb 27
Annual Report
2026
Feb 23
Proxy Solicitation & Information Statement
2026
Feb 23
Regulatory Filings
2026
Feb 17